Our Story

Why research
is SWEET.

A global team of researchers, clinicians, and engineers came together around a single conviction: that rigorous, GCP-compliant clinical research should be accessible to every team — regardless of where they work, how they're funded, or how large their trial is.

Our Origin

Research methodology
deserves better infrastructure

Clinical research is one of humanity's most important endeavors. Every randomised controlled trial, every observational cohort, every patient registry is a step toward better treatments, earlier diagnoses, and longer, healthier lives.

Yet for too long, the tools that power this research — the Electronic Data Capture systems, the audit trails, the query management workflows — have been the preserve of large pharmaceutical companies and well-funded global CROs. A researcher at a district hospital in Jharkhand, a PhD student at JIPMER, or a PI building India's first neurodegenerative disease registry should not face inferior infrastructure simply because of where they work or how their study is funded.

SUCRE EDC was built to close that gap. We combined deep clinical research expertise, a commitment to GCP and ICH E6(R3) compliance, and modern AI-driven technology to create a platform that is simultaneously rigorous enough for Phase III sponsor trials and accessible enough for a student pilot.

"Research is SWEET — because every study, wherever it happens, deserves world-class infrastructure. Science does not discriminate by postcode or budget."
— The SUCRE EDC founding team
01
GCP is non-negotiable
Every feature — from audit trails to query management to e-signatures — is designed around ICH E6(R3) and 21 CFR Part 11. Compliance is never an afterthought.
02
Every trial format is equal
Open-label, single-blind, double-blind, crossover, observational, registry — each trial design deserves the same level of infrastructure. No format is second-class.
03
Technology serves the science
AI, DICOM, IoT integration, offline sync — all of it exists to make data capture more accurate and researchers more efficient, never for its own sake.
04
Accessible to every researcher
A PhD student, a district hospital DEO, and a global pharma sponsor should all have access to great EDC tools. Pricing and complexity should not be barriers.
05
Patients are part of the trial
The patient app, eDiary, IoT wearable integration, and AI conversation tools recognise that subjects are active participants — not passive data sources.
The SWEET Acronym

Every letter is a commitment

SUCRE EDC's name isn't just a brand construct — each letter represents a foundational commitment to how clinical research should be conducted in the 21st century.

S
Studies
Every study deserves world-class infrastructure
Whether it is a Phase I dose-escalation study with 12 subjects, a Phase III randomised controlled trial at 20 sites, or a 10-year longitudinal disease registry — every clinical study is methodologically important and deserves EDC infrastructure that does not compromise on data integrity, audit capability, or regulatory compliance. SUCRE EDC supports all trial formats: RCT, open-label, single-blind, double-blind, crossover, observational, registry, feasibility, and pilot studies.
W
Where
Research happens everywhere — the platform must too
Clinical research in India takes place across an extraordinary range of settings: a tertiary AIIMS with high-speed internet, a CHC in tribal Jharkhand with no reliable connectivity, a private hospital in Mumbai's BKC, a rural PHC in Rajasthan. SUCRE EDC is built offline-first — data captured without connectivity syncs automatically when a connection is available. No data is lost. No workflow is interrupted. The platform works where the research happens.
E
Everyone
Every role in the trial team has the right tools
A clinical trial involves many stakeholders with different needs and different levels of data access. SUCRE EDC's 12-level RBAC system ensures that the Principal Investigator, Sub-Investigator, Data Entry Operator, Clinical Research Associate, Study Coordinator, Medical Monitor, Sponsor Representative, Biostatistician, and Regulatory Affairs professional each sees exactly what they need — no more, no less — in an interface designed for their workflow.
E
Empowered
AI does the grunt work so researchers do the science
AI-assisted data capture, smart query generation, PDF OCR for blood reports and prescriptions, auto-population of eCRF fields — SUCRE EDC's AI layer is designed to remove the administrative burden from clinical research, not to replace clinical judgment. The patient-facing AI conversation interface helps subjects complete eDiary entries and flag adverse symptoms in plain language, making their participation more meaningful and their data more complete.
T
Technology
Technology that serves the science — not the other way around
DICOM and OHIF viewer integration for radiology, OCT and OCTA for ophthalmology, WHO-DD coded medication logs, IoT and wearable device connectivity, REST API for EHR integration, FHIR-compatible data pipelines, offline-first mobile apps — every technology choice in SUCRE EDC was made because it solves a real problem in clinical research workflows. The goal is always better outcomes: cleaner data, fewer errors, faster database lock, more reliable regulatory submissions.
Why We Built This

The gaps we saw
in clinical research

EDC was priced out of reach
Enterprise EDC solutions cost $200–500 per user per month — pricing that excludes academic researchers, grant-funded investigators, and smaller CROs. India's vast clinical research talent and patient population were being underserved.
Offline research was ignored
Most EDC vendors assumed reliable internet. But India's most important population health research happens far from data centres — in district hospitals, tribal health posts, and mobile health camps where connectivity is intermittent or absent.
AI was hype, not utility
Every vendor claimed "AI-powered" but delivered shallow features. We built AI that does real work: reading lab report PDFs, auto-raising queries from outliers, helping patients with multilingual eDiary completion, and reducing SDV burden by 60%.
Patients had no voice
Traditional EDC treated patients as data objects — forms to fill about them, not with them. We built the patient app, eDiary, and AI conversation layer so subjects can actively participate in their trial, improving adherence and data completeness.

Start your research
on SUCRE EDC

Join researchers building groundbreaking studies on India's most GCP-compliant Electronic Data Capture platform.